Latest Regulatory Milestones News

Finbar Group has acquired a prime West Leederville site for $15.7 million, aiming to develop 240 apartments valued at $200 million, with earnings expected by FY2030.

Winsome Resources has received crucial Environmental and Social Impact Assessment guidelines from Québec authorities, marking a significant regulatory milestone for its Adina Lithium Project. This development sets the stage for detailed environmental studies and stakeholder engagement ahead of the project's next phase.

Dynamic Metals has secured heritage and regulatory approvals to commence a targeted 13-hole drilling program at its Chalice South gold prospect, advancing exploration in a proven mineralised corridor in Western Australia.

The Australian Competition and Consumer Commission has signaled no opposition to DP World Australia’s acquisition of Silk Logistics, advancing the deal but leaving key approvals pending.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

Medallion Metals has taken a crucial step by acquiring 258 hectares near Ravensthorpe to meet environmental offset requirements, advancing its gold project approvals under federal law.

MRG Metals has achieved a pivotal milestone with the granting of the Corridor South 11137 Mining Licence in Mozambique, setting the stage for production within 12 to 18 months under its fully funded Corridor Sands Project.

Artrya Limited announces a strategic leadership reshuffle with co-founder John Konstantopoulos stepping into the CEO role as the company prepares for its U.S. commercial launch of the Salix® AI-powered platform.

Jindalee Lithium has appointed Ian Rodger as Managing Director, marking a leadership milestone as the company advances its McDermitt Lithium Project. Rodger’s promotion follows his pivotal role in delivering key project studies and securing regulatory milestones.

LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.